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Objectives Flexible sigmoidoscopy (FS) screening for colorectal cancer will be introduced into
the National Cancer Screening Programmes in England in 2013. Patient-reported outcome
measures (PROMs) from trial participants indicate high acceptability and no adverse physical or
psychological consequences, but this may not generalize to routine screening in the community.
This study examined PROMs in a community-based FS screening programme.
Methods Eligible adults aged 58–59 (n ¼ 2016) registered at 34 London general practices were
mailed a National Health Service-endorsed invitation to attend FS screening. Pain and side-effects
were assessed in a ‘morning-after’ questionnaire, and satisfaction was assessed in a three-month
follow-up questionnaire. Anxiety, self-rated health and colorectal symptoms were assessed at
prescreening and follow-up.
Results In total, 1020 people attended screening and were included in the current analyses, of
whom 913 (90%) returned the morning-after questionnaire, and 674 (66%) the follow-up
questionnaire. The prescreening questionnaire had been completed by 751 (74%) of those who
attended. The majority (87%) of respondents reported no pain or mild pain, and the most frequent
side-effect (wind) was only experienced more than mildly by 16%. Satisfaction was extremely high,
with 98% glad they had the test; 97% would encourage a friend to have it. From prescreening to
follow-up there were no changes in anxiety or self-rated health, and the number of colorectal
symptoms declined. Satisfaction and changes in wellbeing were not moderated by gender,
deprivation, ethnicity or screening outcome.
Conclusions PROMs indicate high acceptability of FS screening in 58–59 year olds, with no
adverse effects on colorectal symptoms, health status or psychological wellbeing.
INTRODUCTION
T
he UK Flexible Sigmoidoscopy (FS) Trial showed that
a single endoscopic examination at age 55–64
reduced colorectal cancer (CRC) incidence by 33%
and mortality by 43% over an 11-year follow-up period.1
Positive results have also been reported in trials from the
USA and Italy.2,3 FS screening is already recommended in
the USA and is to be introduced into the English national
CRC screening programme as a single test at age 55.4,5
Because screening tests are offered to people who are typi-
cally asymptomatic and ‘healthy’, the psychological costs
and benefits of screening participation are important clinical
indicators. Patient-reported outcomes measures (PROMs)
are therefore an essential component of the evaluation.6
They also help to identify opportunities to improve the
screening service, and make it possible to identify socioeco-
nomic or ethnic differences in the experience of screening
that could contribute to inequalities in uptake.7
In both the UK and the Norwegian Trials, acceptability of
FS screening was very high.8 – 11 However, trial participants
are a research volunteer population, and outcomes in the
trial context may not generalize to screening delivered as
part of a population-based programme. This study therefore
examined patient satisfaction, and measures of health and
wellbeing in a ‘demonstration’ project in which FS screening
was offered to all eligible adults in an ethnically and socio-
economically diverse area of London, England.12
METHODS
Participants and procedures
The demonstration project was carried out between
November 2006 and May 2008 in two ethnically diverse
North London boroughs. General Practices (n ¼ 34) from
areas spanning a wide range of socioeconomic status based
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on the Index of Multiple Deprivation (IMD)13 were invited
to participate. All men and women aged 58–59 (n ¼ 2260)
registered with the Practices were sent an invitation to
FS screening. Invitation recipients were asked to contact
the screening clinic to discuss their suitability for the test if
they had one of following conditions: bowel cancer, any
inflammatory bowel disease, kidney failure (on dialysis),
artificial heart valve, taking warfarin, recent heart attack
(last 6 months), awaiting heart surgery or coronary angio-
plasty, any other serious illness, any bowel examinations in
the last 3 years. Ethical approval was obtained from the
local National Health Service Research Ethics Committee.
Invitations were sent six weeks before the screening ap-
pointment with the request to confirm, decline or change
the appointment. Information about the test and a pre-
screening questionnaire were included. After two weeks,
non-responders were sent a reminder and another question-
naire. A week before the appointment, patients were sent an
enema to self-administer an hour before leaving home for
the FS test.
FS was performed with a standard 140 cm Olympus
colonoscope without sedation. The aim was to reach the
junction of the sigmoid and descending colon without
causing undue pain or distress. Carbon dioxide was used
to insufflate the bowel.
Those who attended and underwent the test were asked
to complete a brief questionnaire the morning after the
test asking about their experiences. A follow-up question-
naire was mailed after three months to allow time for any
further procedures (e.g. colonoscopy) to be completed.
Measures
Demographic variables
Age, gender and home address were obtained from GP
records. Individual socioeconomic status was indexed using
IMD rank for the home address, and categorized into quin-
tiles. The prescreening survey included ethnicity items
from the UK Census,14 but due to the large number of differ-
ent ethnic subgroups and the small number within each
group, responses were recoded into non-white versus
white for analysis.
Screening outcome
Screening outcome was recorded by the endoscopist: no
polyps; ‘low-risk’ polyps; ‘high-risk’ polyps, with low-risk
polyps removed and patients discharged. Patients with ‘high-
risk’ polyps (categorized following British Society of
Gastroenterology guidelines which included any of: three
or more adenomas; diameter 1 cm or larger; tubulovillous
or villous histology; severe dysplastia or malignancy) were
referred to colonoscopy. All polyps removed during screen-
ing and colonoscopy were sent for histological analysis.
Experience of the test (morning-after questionnaire)
Experience of pain was recorded with two questions: ‘How
much pain did you feel during the test?’ (none/mild/quite a lot/
severe) and ‘Was the test more painful or less painful than
expected’ (less painful/about the same/more painful).
Side-effects were assessed with the question: ‘Did you have
any of the following after the test’: abdominal pains/cramps,
nausea/vomiting, faint feeling or dizziness, wind, bottom soreness,
soiling, sleep disturbance (none/mild/moderate/severe). A final
open-ended question asked: ‘Do you have any other comments
about any aspect of the test’. Responses were coded as positive,
negative, neutral and both positive and negative by two
independent coders (KR and SHL), with a kappa inter-rater
reliability of 0.87.
Satisfaction (three-month follow-up)
Satisfaction with the procedure overall was assessed
with two items: ‘On balance, were you glad you had the test’
(yes/no/not sure) and ‘If a friend asked you if they should have
the test, would you encourage or discourage them’ (strongly encou-
rage/encourage/neither/discourage/strongly discourage). Satisfac-
tion with individual elements of the test was assessed with
four items: ‘How satisfied were you with. . .’ (a) ‘the information
you were given before your test’; (b) ‘the facilities at the unit’;
(c) ‘the attitude of the staff’; and (d) ‘the way the results of the
test were explained’; with response options of: very satisfied,
satisfied, dissatisfied and very dissatisfied.
Health and wellbeing from prescreening to follow-up
Colorectal symptoms were assessed in both prescreening
and three-month follow-up questionnaires. Prescreening,
the stem of the question read: ‘Because we are studying bowel
screening, we would like to know how often people get these
bowel symptoms. In the last three months have you . . .’. At
follow-up, the stem was: ‘Because you’ve recently had the
Flexi-Scope Test we would like to know how often you’ve had
these bowel symptoms and bowel problems. Since you had the test
have you. . .’. Symptoms listed were: ‘constipated’, ‘haemor-
rhoids (piles)’, ‘diarrhoea’, ‘wind’, ‘pains in the abdomen
(gut)’, ‘bowel incontinence’ and ‘blood in your stools’ (no/
occasionally/frequently). A symptom score was created as the
sum of the items reported as having occurred ‘occasionally’
or ‘frequently’ (range: 0–7).10
Self-rated health was assessed before screening and at
follow-up with ‘Would you say that for someone of your age
your own health in general is. . .’ (excellent/good/fair/poor).
This has been shown to be valid in middle-aged adults.15
For analysis, responses were recoded into excellent/good
vs. fair/poor.
Anxiety was assessed before screening and at follow-up
with a 4-item version of the Spielberger State Anxiety
Inventory.16,17 People are asked how they feel ‘right now’,
with the following items: ‘I feel calm’, ‘I am tense’, ‘I feel
upset’ and ‘I am relaxed’ (not at all/somewhat/moderately/very
much). Scores were multiplied by 20 to be comparable with
the full STAI (range: 20–80), and a cut-off of 44 was used
to indicate clinical levels of anxiety.18
Statistical analysis
Because data were skewed, non-parametric methods were
used. We tested for differences in pain, side-effects, and sat-
isfaction by demographic characteristics (gender, area-level
deprivation, ethnicity) and screening results using the
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Mann-Whitney U test (two groups) and the Kruskal-Wallis
test (three or more groups); using a P value of , 0.01
because of multiple testing. Among respondents who com-
pleted both prescreening and follow-up questionnaires, we
examined change using Wilcoxon signed-rank. Data were
analysed using SPSS version 17.
RESULTS
Sample characteristics
Of 2260 people sent the screening invitation, 244 were ineli-
gible and 1024 (51% of the eligible sample) attended.12 Two
patients were found to have cancer and were excluded from
analyses, and two others attended but were unable
to undergo the test due to poor bowel preparation; it is
not known why the test was not rescheduled. Of the
remaining 1020 people screened, 751 (74%) had returned
the prescreening questionnaire, 913 (90%) completed the
morning-after questionnaire and 674 (66%) returned
the three-month follow-up questionnaire. There were no
differences in questionnaire response rates by gender,
deprivation or screening outcome.
Pain and experience of side-effects
Of the 913 participants returning the morning-after ques-
tionnaire, 87% reported no pain or mild pain during the
test, and less than 1% described the pain as severe
(Table 1). The procedure was less painful than expected
for 51% of respondents and more painful for 14%.
Fewer women than men reported only none or mild pain
(81% versus 93%; z ¼ 25.35, P, 0.001), and more
women than men found it more painful than they
expected (18% versus 9%; z ¼ 23.36, P ¼ 0.001). There
were no differences by ethnicity or deprivation.
The most common side-effect to reach moderate/severe
levels was wind (16%), with abdominal pains and cramps
the next most commonly reported (7%). Less than 4% of
respondents experienced moderate/severe levels of any
other side-effect. Women reported abdominal pain more
often than men (10% versus 4%; z ¼ 23.96, P, 0.001)
but there were no other gender differences, and no differ-
ences by ethnicity or deprivation.
Participants’ responses to ‘any other comments’
In total, 482 participants of the 913 returning the morning-
after questionnaire made written responses to the open-
ended question. Responses were predominantly positive
(74%) with 15% coded as positive and negative, 8% as
negative and 3% as neutral. Illustrative quotes are presented
in Box 1.
Satisfaction (3-month follow-up)
Satisfaction with the flexible sigmoidoscopy test was very
high at follow-up (Table 2), with almost all (98%) respon-
dents glad they had the test, while 97% would strongly
encourage a friend to have it. Satisfaction with specific
aspects of the procedure was also very high, with responses
of ‘satisfied’ or ‘very satisfied’ reported by 98% for the pre-
screening information, 97% for the facilities, 99% with the
attitude of the staff and 98% with how the test results had
Table1 Flexible sigmoidoscopy (FS) screening attenders’ (n ¼ 1020) response to the morning-after questionnaire
Total
% n
Number of questionnaires returned 89.5 913
How much pain did you feel during the test? (n ¼ 884)†
None or mild 87.2 771
Quite a lot 11.9 105
Severe 0.9 8
Was the test more painful or less painful than you expected? (n ¼ 853)†
Less painful 51.3 438
About the same 34.6 295
More painful 14.1 120
Did you have any of the following after the test?
Abdominal pains/cramps (n ¼ 860)†
Moderate or severe 7.0 60
Nausea/vomiting (n ¼ 822)†
Moderate or severe 0.4 3
Faint feeling or dizziness (n ¼ 832)†
Moderate or severe 1.2 10
Wind (n ¼ 874)†
Moderate or severe 16.5 144
Bottom soreness (n ¼ 834)†
Moderate or severe 3.4 28
Soiling (n ¼ 817)†
Moderate or severe 1.0 8
Sleep disturbance (n ¼ 815)†
Moderate or severe 2.3 19
Not every question was answered on completed forms. Percentages are of those who completed the particular question
†Total number of responses to each question
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been explained. There were no significant differences by
gender, deprivation or ethnicity.
Box 1 Illustrative quotes from the questionnaire
completed the morning after FS coded as positive,
positive and negative, negative and neutral
Positive
‘I was very happy by how easy it all was and how little
time the test took. Thank you.’ Male, White British,
most deprived IMD quintile.
‘Communication and explanation by the staff made
me feel very relaxed. Procedure was performed very
gently as well. I had three polyps removed, did not
feel a thing.’ Female, Indian, third most deprived
IMD quintile.
‘Very quick and efficient. Did not take as long as
anticipated. Staff very friendly and helpful and reas-
suring. Interesting to see pictures of my colon – a
first for me!’ Female, White British, second most
deprived IMD quintile.
Positive and negative
‘I found the procedure very painful however I was
relieved that the test was negative.’ Female,
Caribbean, third most deprived IMD quintile.
‘Prior to the test I was scared, but the staff were very
sympathetic and helpful to calm down my anxiety
and [feelings of discomfort]. I [had] this test to
avoid any unforeseen problems.’ Female, Pakistani,
most deprived IMD quintile.
Negative
‘The preparation [enema] at home before the test
made me feel uncomfortable.’ Male, White British,
third most deprived IMD quintile.
‘When discussing patients’ results I believe this should
be done in private not in front of other patients as this
can be disconcerting to patients.’ Male, White British,
most affluent IMD quintile.
Neutral
‘This test should be carried out once every 18 months’
Male, Caribbean, second most deprived IMD quintile
‘I felt like passing wind during the test not after. [The]
next day my first motion was loose.’ Male, Indian,
third most deprived IMD quintile.
Patient-reported outcomes by screening result
Seventy-five percent of participants had a negative result,
19% had ‘low risk’ polyps requiring no further investigation,
and 5% had ‘high risk’ polyps and were referred for colono-
scopy. There were no differences in satisfaction, pain or side-
effects by screening outcome.
Changes in health and wellbeing from prescreening
to follow-up
We examined change in number of colorectal symptoms,
self-reported health and anxiety among participants
(n ¼ 534, 52%) who returned both the prescreening and
follow-up questionnaires. There were no differences on pre-
screening scores among those who did and did not complete
follow-up.
On average, respondents reported 0.81 fewer colorectal
symptoms at the three-month follow-up than prescreening
(Table 3). No significant changes were found for anxiety or
self-reported health. Results did not differ by gender, depri-
vation, ethnicity or screening outcome.
DISCUSSION
The results of this study indicate that the acceptability of
population-based FS screening, delivered in a similar
manner to the UK’s population-based national screening
programme, was extremely high. Patient-reported outcomes
were strikingly comparable with those found in the
gastroenterologist-led UK FS Trial, which invited only indi-
viduals who had indicated they were interested in taking
part in the Trial.8– 10
Overall, 98% of participants were glad they had the test
and 97% would encourage a friend to have it. Half the
participants (51%) found FS less painful than they expected
and less than 1% reported severe pain. Side-effects were
minimal, and the most common, wind, reported by only
16%.
There were few demographic differences, but women
reported more abdominal pain following the procedure
which is consistent with previous work.19 Strategies to
address pain, particularly in women, could help improve
FS screening programmes. It was reassuring that no detri-
mental differences were found by deprivation or ethnicity,
and based on these results, participant experience is unlikely
to drive inequalities in uptake.7
We found no evidence that self-reported health or anxiety
changed from before to three months after the test, and col-
orectal symptoms declined. Results were similar for patients
with or without polyps, suggesting that the impact of polyp
removal on wellbeing was minimal. This is consistent
with findings from the gastroenterologist-led UK FS Trial,
with the sole difference being a reduction in anxiety in the
previous study.10
It is possible that the high patient satisfaction could be
partly attributed to staff attitude and behaviour, which can
be difficult to regulate in a nationwide programme. In this
demonstration pilot, screening was delivered by experienced
nurse endoscopists who were well-trained to practice in the
screening setting as documented in a previous qualitative
study.20 Staff training is important given the differences in
screening and diagnostic services. Using PROMs as part of
ongoing audit of services once FS screening is implemented
nationally would make it possible both to assess service
characteristics and to give feedback to screening centres.
A further limitation is that the satisfaction results are based
on the 66% of FS screening participants completing the
follow-up questionnaire. However, follow-up responders
did not differ from non-responders on any of the available
demographic characteristics (gender, area-level deprivation).
Comparing the findings with the potentially more motivated
UK FS Trial participants, where 94% returned the follow-
up questionnaire, satisfaction levels only differed slightly.
This suggests that these positive results may generalize
4 Robb et al.
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to the screening eligible population in a national FS
programme.
CONCLUSION
Patient-reported outcomes indicate high acceptability of
flexible sigmoidoscopy screening delivered by specialist
nurse endoscopists in a socioeconomically and ethnically
diverse community sample. Screening had no adverse
impact on colorectal symptoms, self-reported health or
anxiety.
. . . . . . . . . . . . . . .
Authors’ affiliations
Kathryn A. Robb, PhD, Cancer Research UK Post-doctoral Fellow,
Institute of Health and Wellbeing, University of Glasgow, Glasgow
G12 8RZ, UK
Siu Hing Lo, PhD, Research Associate in Health Psychology, Health
Behaviour Research Centre, Department of Epidemiology and Public
Health, University College London, Gower Street, London WC1E
6BT, UK
Emily Power, PhD, Research Associate in Health Psychology, Health
Behaviour Research Centre, Department of Epidemiology and Public
Health, University College London, Gower Street, London WC1E
6BT, UK
Ines Kralj-Hans, PhD, Research Manager, Department of Surgery
and Cancer, Imperial College London, London, UK
Robert Edwards, PhD, Statistician and Group Head, Centre for
Epidemiology, Mathematics and Statistics, Wolfson Institute of
Preventive Medicine, London, UK
Maggie Vance, Nurse Consultant, Wolfson Endoscopy Unit,
St Mark’s Hospital, Harrow, UK
Christian von Wagner, PhD, Senior Research Associate, Health
Behaviour Research Centre, Department of Epidemiology and Public
Health, University College London, Gower Street, London WC1E
6BT, UK
Wendy Atkin, PhD, Professor of Gastrointestinal Epidemiology,
Department of Surgery and Cancer, Imperial College London,
London, UK
Jane Wardle, PhD, Professor of Clinical Psychology and Director of
the Health Behaviour Research Centre, Department of Epidemiology
and Public Health, University College London, Gower Street, London
WC1E 6BT, UK
ACKNOWLEDGEMENTS
Funding from the Department of Health and Cancer
Research UK is gratefully acknowledged.
Table 3 Changes in colorectal symptoms, general health and anxiety from before to three months after screening among
respondents to both questionnaires (n ¼ 534)
Prescreening Follow-up Significance
Mean (SD) colorectal symptoms (n ¼ 534) 2.00 (1.61) 1.19 (1.37) z ¼ 211.26, P, 0.0001
% excellent/good self-rated health (n ¼ 502) 72.7 (n ¼ 365) 72.9 (n ¼ 366) z ¼ 20.114 P ¼ 0.909
% anxious (n ¼ 502) 27.7 (n ¼ 139) 25.5 (n ¼ 128) z ¼ 20.933, P ¼ 0.351
Total number of responses to both questions
Table 2 Flexible sigmoidoscopy (FS) screening attenders’ (n ¼ 1020) response to satisfaction measures three months after FS
Total
% N
Number of questionnaires returned 66.1 674
On balance, were you glad you had the test? (n ¼ 615)†
Yes 97.9 602
No 0.5 3
Not sure 1.6 10
If a friend asked you if they should have the test, would you encourage them? (n ¼ 621)†
Strongly encourage/encourage 97.3 604
Neither 2.4 15
Discourage/strongly discourage 0.3 2
How satisfied were you with the information you were given before your test? (n ¼ 654)†
Very satisfied/satisfied 98.2 642
Dissatisfied/very dissatisfied 1.8 12
How satisfied were you with the facilities at the Flexi-Scope unit? (n ¼ 655)†
Very satisfied/satisfied 97.4 638
Dissatisfied/very dissatisfied 2.6 17
How satisfied were you with the attitude of the staff at the unit? (n ¼ 655)†
Very satisfied/satisfied 99.4 651
Dissatisfied/very dissatisfied 0.6 4
How satisfied were you with the way the results of the test were explained to you? (n ¼ 655)†
Very satisfied/satisfied 97.6 639
Dissatisfied/very dissatisfied 2.4 16
Not every question was answered on completed forms. Percentages are of those who completed the particular question
†Total number of responses to each question
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